GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » EV-to-EBITDA

CTC Bio (XKRX:060590) EV-to-EBITDA : -31.65 (As of Jun. 23, 2024)


View and export this data going back to 2002. Start your Free Trial

What is CTC Bio EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CTC Bio's enterprise value is ₩205,238 Mil. CTC Bio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-6,485 Mil. Therefore, CTC Bio's EV-to-EBITDA for today is -31.65.

The historical rank and industry rank for CTC Bio's EV-to-EBITDA or its related term are showing as below:

XKRX:060590' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1174.67   Med: 22.5   Max: 454.21
Current: -31.65

During the past 13 years, the highest EV-to-EBITDA of CTC Bio was 454.21. The lowest was -1174.67. And the median was 22.50.

XKRX:060590's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Biotechnology industry
Industry Median: 8.545 vs XKRX:060590: -31.65

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), CTC Bio's stock price is ₩7980.00. CTC Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-592.000. Therefore, CTC Bio's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


CTC Bio EV-to-EBITDA Historical Data

The historical data trend for CTC Bio's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTC Bio EV-to-EBITDA Chart

CTC Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -98.79 -15.96 106.90 16.96 -40.84

CTC Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.52 -614.31 -90.10 -40.84 -34.23

Competitive Comparison of CTC Bio's EV-to-EBITDA

For the Biotechnology subindustry, CTC Bio's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTC Bio's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CTC Bio's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CTC Bio's EV-to-EBITDA falls into.



CTC Bio EV-to-EBITDA Calculation

CTC Bio's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=205238.335/-6484.969
=-31.65

CTC Bio's current Enterprise Value is ₩205,238 Mil.
CTC Bio's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,485 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTC Bio  (XKRX:060590) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CTC Bio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7980.00/-592.000
=At Loss

CTC Bio's share price for today is ₩7980.00.
CTC Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-592.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


CTC Bio EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CTC Bio's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CTC Bio (XKRX:060590) Business Description

Traded in Other Exchanges
N/A
Address
94, Saengmyeonggwahakgwan-gil, Gangwon-do, Hongcheon, KOR, 25142
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

CTC Bio (XKRX:060590) Headlines

No Headlines